Cargando…
Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019
BACKGROUND: The benefit of intravenous thrombolysis is time dependent. It remains unclear, however, whether dramatic shortening of door‐to‐needle time (DNT) among different types of hospitals nationwide does not compromise safety and still improves outcome. METHODS AND RESULTS: Multifaceted interven...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238542/ https://www.ncbi.nlm.nih.gov/pubmed/35574953 http://dx.doi.org/10.1161/JAHA.121.023524 |
_version_ | 1784737078015164416 |
---|---|
author | Mikulík, Robert Bar, Michal Bělašková, Silvie Černík, David Fiksa, Jan Herzig, Roman Jura, René Jurák, Lubomír Klečka, Lukáš Neumann, Jiří Ostrý, Svatopluk Šaňák, Daniel Ševčík, Petr Škoda, Ondřej Šrámek, Martin Tomek, Aleš Václavík, Daniel |
author_facet | Mikulík, Robert Bar, Michal Bělašková, Silvie Černík, David Fiksa, Jan Herzig, Roman Jura, René Jurák, Lubomír Klečka, Lukáš Neumann, Jiří Ostrý, Svatopluk Šaňák, Daniel Ševčík, Petr Škoda, Ondřej Šrámek, Martin Tomek, Aleš Václavík, Daniel |
author_sort | Mikulík, Robert |
collection | PubMed |
description | BACKGROUND: The benefit of intravenous thrombolysis is time dependent. It remains unclear, however, whether dramatic shortening of door‐to‐needle time (DNT) among different types of hospitals nationwide does not compromise safety and still improves outcome. METHODS AND RESULTS: Multifaceted intervention to shorten DNT was introduced at a national level, and prospectively collected data from a registry between 2004 and 2019 were analyzed. Generalized estimating equation was used to identify the association between DNT and outcomes independently from prespecified baseline variables. The primary outcome was modified Rankin score 0 to 1 at 3 months, and secondary outcomes were parenchymal hemorrhage/intracerebral hemorrhage (ICH), any ICH, and death. Of 31 316 patients treated with intravenous thrombolysis alone, 18 861 (60%) had available data: age 70±13 years, National Institutes of Health Stroke Scale at baseline (median, 8; interquartile range, 5–14), and 45% men. DNT groups 0 to 20 minutes, 21 to 40 minutes, 41 to 60 minutes, and >60 minutes had 3536 (19%), 5333 (28%), 4856 (26%), and 5136 (27%) patients. National median DNT dropped from 74 minutes in 2004 to 22 minutes in 2019. Shorter DNT had proportional benefit: it increased the odds of achieving modified Rankin score 0 to 1 and decreased the odds of parenchymal hemorrhage/ICH, any ICH, and mortality. Patients with DNT ≤20 minutes, 21 to 40 minutes, and 41 to 60 minutes as compared with DNT >60 minutes had adjusted odds ratios for modified Rankin score 0 to 1 of the following: 1.30 (95% CI, 1.12–1.51), 1.33 (95% CI, 1.15–1.54), and 1.15 (95% CI, 1.02–1.29), and for parenchymal hemorrhage/ICH: 0.57 (95% CI, 0.45–0.71), 0.76 (95% CI, 0.61–0.94), 0.83 (95% CI, 0.70–0.99), respectively. CONCLUSIONS: Ultrashort initiation of thrombolysis is feasible, improves outcome, and makes treatments safer because of fewer intracerebral hemorrhages. Stroke management should be optimized to initiate thrombolysis as soon as possible optimally within 20 minutes from arrival to a hospital. |
format | Online Article Text |
id | pubmed-9238542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92385422022-06-30 Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019 Mikulík, Robert Bar, Michal Bělašková, Silvie Černík, David Fiksa, Jan Herzig, Roman Jura, René Jurák, Lubomír Klečka, Lukáš Neumann, Jiří Ostrý, Svatopluk Šaňák, Daniel Ševčík, Petr Škoda, Ondřej Šrámek, Martin Tomek, Aleš Václavík, Daniel J Am Heart Assoc Original Research BACKGROUND: The benefit of intravenous thrombolysis is time dependent. It remains unclear, however, whether dramatic shortening of door‐to‐needle time (DNT) among different types of hospitals nationwide does not compromise safety and still improves outcome. METHODS AND RESULTS: Multifaceted intervention to shorten DNT was introduced at a national level, and prospectively collected data from a registry between 2004 and 2019 were analyzed. Generalized estimating equation was used to identify the association between DNT and outcomes independently from prespecified baseline variables. The primary outcome was modified Rankin score 0 to 1 at 3 months, and secondary outcomes were parenchymal hemorrhage/intracerebral hemorrhage (ICH), any ICH, and death. Of 31 316 patients treated with intravenous thrombolysis alone, 18 861 (60%) had available data: age 70±13 years, National Institutes of Health Stroke Scale at baseline (median, 8; interquartile range, 5–14), and 45% men. DNT groups 0 to 20 minutes, 21 to 40 minutes, 41 to 60 minutes, and >60 minutes had 3536 (19%), 5333 (28%), 4856 (26%), and 5136 (27%) patients. National median DNT dropped from 74 minutes in 2004 to 22 minutes in 2019. Shorter DNT had proportional benefit: it increased the odds of achieving modified Rankin score 0 to 1 and decreased the odds of parenchymal hemorrhage/ICH, any ICH, and mortality. Patients with DNT ≤20 minutes, 21 to 40 minutes, and 41 to 60 minutes as compared with DNT >60 minutes had adjusted odds ratios for modified Rankin score 0 to 1 of the following: 1.30 (95% CI, 1.12–1.51), 1.33 (95% CI, 1.15–1.54), and 1.15 (95% CI, 1.02–1.29), and for parenchymal hemorrhage/ICH: 0.57 (95% CI, 0.45–0.71), 0.76 (95% CI, 0.61–0.94), 0.83 (95% CI, 0.70–0.99), respectively. CONCLUSIONS: Ultrashort initiation of thrombolysis is feasible, improves outcome, and makes treatments safer because of fewer intracerebral hemorrhages. Stroke management should be optimized to initiate thrombolysis as soon as possible optimally within 20 minutes from arrival to a hospital. John Wiley and Sons Inc. 2022-05-16 /pmc/articles/PMC9238542/ /pubmed/35574953 http://dx.doi.org/10.1161/JAHA.121.023524 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Mikulík, Robert Bar, Michal Bělašková, Silvie Černík, David Fiksa, Jan Herzig, Roman Jura, René Jurák, Lubomír Klečka, Lukáš Neumann, Jiří Ostrý, Svatopluk Šaňák, Daniel Ševčík, Petr Škoda, Ondřej Šrámek, Martin Tomek, Aleš Václavík, Daniel Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019 |
title | Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019 |
title_full | Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019 |
title_fullStr | Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019 |
title_full_unstemmed | Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019 |
title_short | Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019 |
title_sort | ultrashort door‐to‐needle time for intravenous thrombolysis is safer and improves outcome in the czech republic: nationwide study 2004 to 2019 |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238542/ https://www.ncbi.nlm.nih.gov/pubmed/35574953 http://dx.doi.org/10.1161/JAHA.121.023524 |
work_keys_str_mv | AT mikulikrobert ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT barmichal ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT belaskovasilvie ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT cernikdavid ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT fiksajan ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT herzigroman ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT jurarene ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT juraklubomir ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT kleckalukas ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT neumannjiri ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT ostrysvatopluk ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT sanakdaniel ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT sevcikpetr ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT skodaondrej ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT sramekmartin ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT tomekales ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT vaclavikdaniel ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 AT ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019 |